[18F]FDG标记白细胞PET/CT诊断感染性疾病的初步经验
本研究在三级中心探讨[18F]FDG标记白细胞PET/CT诊断疑似感染性疾病的可行性、安全性和准确性,共随访14个病灶。结果显示灵敏度82%、特异度100%,假阴性病灶位于中轴骨和近端骨骼;标记效率在糖尿病患者中较低,操作者和患者安全性良好。
要点
- 14个病灶随访中,[18F]FDG标记白细胞PET/CT灵敏度82%、特异度100%。
- 假阴性病灶位于中轴骨和近端骨骼,提示该部位病变诊断受限。
- 放射性标记效率在糖尿病与非糖尿病患者间差异有统计学意义。
核心结论
- [18F]FDG标记白细胞PET/CT评估动态变化可行且诊断性能很好,但对中轴骨骼和网状内皮系统病灶有局限。
- 该操作对操作者和患者安全,但仍需改进标记时的屏蔽并开展更大样本研究。
研究设计与样本
- 单中心初步研究,在三级中心纳入疑似感染性疾病患者,随访14个identified病灶。
- 在[18F]FDG标记白细胞给药后131±13分钟和201±16分钟进行扫描。
主要发现
- [18F]FDG标记白细胞PET/CT的灵敏度/特异度为82%/100%。
- 假阴性病灶位于中轴骨和近端骨骼。
- 感染病灶SUVmax@2h为10.4±8.8,SUVmax@3h为13.9±12.3。
- 感染病灶aSUV为3.5±4.3,rSUV为34.2±29.1。
- 放射性标记效率为74.8±19.4%,糖尿病患者与非糖尿病患者分别为84.9±5.34%与57.9±22.3%(p<0.025)。
关键数值与推荐
- [18F]FDG标记白细胞PET/CT诊断感染的灵敏度为82%、特异度为100%。
- 感染病灶SUVmax@2h为10.4±8.8,SUVmax@3h为13.9±12.3;aSUV为3.5±4.3,rSUV为34.2±29.1。
- 放射性标记效率为74.8±19.4%,糖尿病患者84.9±5.34%,非糖尿病57.9±22.3%(p<0.025)。
- 操作者剂量:躯干轴向39.3±11.8 µSv,四肢69.1±26.2 µSv。
临床怎么用
- 对于疑似感染性疾病,可考虑[18F]FDG标记白细胞PET/CT,但中轴骨和近端骨骼病灶可能出现假阴性。
- 糖尿病患者标记效率较低,操作时需注意放射性防护并优化屏蔽。
局限性
- 样本量小,仅随访14个病灶,需更大样本研究验证。
- 对中轴骨骼和网状内皮系统病灶诊断有限。
- 放射性标记过程中屏蔽措施仍需改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Labelling WBC with [18F]FDG may be an alternative for accurate infection diagnosis, combining the excellent sensitivity of [18F]FDG with the excellent specificity of WBC-labelled SPECT/CT. We aim to investigate the feasibility, safety and accuracy of [18F]FDG-labelled WBC in patients with suspected infectious disease. RESULTS: Scans were performed at 131 ± 13 min and 201 ± 16 min after [18F]FDG-labelled WBC administration. 14 identified lesions were follow-up. [18F]FDG-labelled WBC PET/CT yielded a sensitivity / specificity of 82% / 100%. False negative lesions were localized in axial and proximal skeleton. SUVmax@2h and SUVmax@3h for infected lesions were 10.4 ± 8.8 and 13.9 ± 12.3. aSUV and rSUV values for infected lesions were 3.5 ± 4.3 and 34.2 ± 29.1 Radiolabelling efficiency was 74.8 ± 19.4% (84.9 ± 5.34% vs. 57.9 ± 22.3%, p < 0.025 in diabetic vs. non-diabetic). The dose to the operator were 39.3 ± 11.8 µSv for the axial body and 69.1 ± 26.2 µSv for the extremities. CONCLUSIONS: Assessing the dynamic of [18F]FDG-labelled WBC is feasible and yielded a very good diagnostic performance, however with some limitation for lesion of the axial skeleton and the reticuloendothelial system. Moreover, the procedure is operator and patient safe. Improvement in shielding during radiolabelling as well as further investigations with larger population are still needed.
引用
- Kamani CH, Costes J, Panchaud M, et al. [18F]FDG WBC labelled PET/CT for the diagnosis of infectious disease: initial experience in a tertiary centre. EJNMMI Res. 2026. PMID: 41945271. doi:10.1186/s13550-026-01422-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。